PAVmed (PAVM) Cash from Operations (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.33% |
| Sep 30, 2025 | 25.00% |
| Jun 30, 2025 | 25.00% |
| Mar 31, 2025 | -1,802.13% |
| Jun 30, 2024 | 11.08% |
| Mar 31, 2024 | -10.40% |
| Dec 31, 2023 | -7.08% |
| Sep 30, 2023 | 12.76% |
| Jun 30, 2023 | 22.31% |
| Mar 31, 2023 | 2.74% |
| Dec 31, 2022 | 13.02% |
| Sep 30, 2022 | 14.26% |
| Jun 30, 2022 | -83.95% |
| Mar 31, 2022 | 26.91% |
| Dec 31, 2021 | -109.24% |
| Sep 30, 2021 | -20.97% |
| Jun 30, 2021 | 27.71% |
| Mar 31, 2021 | -36.27% |
| Dec 31, 2020 | -15.21% |
| Sep 30, 2020 | -5.13% |
| Jun 30, 2020 | -46.53% |
| Mar 31, 2020 | 7.31% |
| Dec 31, 2019 | -42.11% |
| Sep 30, 2019 | -14.25% |
| Jun 30, 2019 | 34.91% |
| Mar 31, 2019 | -28.18% |
| Dec 31, 2018 | -61.76% |
| Sep 30, 2018 | -9.65% |
| Jun 30, 2018 | 22.62% |
| Mar 31, 2018 | -38.61% |
| Dec 31, 2017 | 33.10% |
| Sep 30, 2017 | -188.05% |
| Jun 30, 2017 | 54.87% |
| Mar 31, 2017 | -51.72% |
| Dec 31, 2016 | 1.95% |
| Sep 30, 2016 | 18.56% |
| Jun 30, 2016 | -190.42% |
| Mar 31, 2016 | 19.96% |
| Dec 31, 2015 | -103.92% |
| Sep 30, 2015 | -40.48% |
| Jun 30, 2015 | -292.79% |